Table III.
Effica |
Pegasos |
Finstar |
p-value | ||||
N | % (95% CI) | n | %(95% CI) | n | % (95% CI) | ||
Patient history | |||||||
Poor | 87 | 74 (65–82) | 18 | 56 (38–74) | 14 | 54 (33–73) | 0.003 |
Moderate | 24 | 21 (14–29) | 7 | 22 (9–40) | 11 | 42 (23–63) | |
Good | 6 | 5 (2–11) | 7 | 22 (9–40) | 1 | 4 (0–20) | |
Acute problem | |||||||
Poor | 24 | 21 (14–29) | 2 | 6 (1–21) | 2 | 8 (1–21) | 0.140 |
Moderate | 60 | 51 (42–61) | 16 | 50 (32–68) | 16 | 50 (32–68) | |
Good | 33 | 28 (20–37) | 14 | 44 (26–62) | 14 | 44 (26–62) | |
Status | |||||||
Poor | 52 | 44 (35–54) | 5 | 16 (5–33) | 10 | 38 (20–60) | 0.006 |
Moderate | 37 | 32 (23–41) | 18 | 28 (14–47) | 6 | 23 (9–44) | |
Good | 28 | 24 (17–33) | 56 (38–74) | 10 | 38 (20–60) | ||
Treatment | |||||||
Poor | 7 | 6 (2–12) | 0 | 0 | 1 | 4 (0–20) | <0.001 |
Moderate | 73 | 62 (53–71) | 13 | 41 (24–60) | 17 | 65 (44–83) | |
Good | 22 | 19 (12–27) | 19 | 59 (41–76) | 2 | 8 (1–25) | |
No treatment | 10 | 9 (4–15) | 0 | 0 | 6 | 23 (9–45) | |
Only prescriptions | 5 | 4 (1–10) | 0 | 0 | 0 | 0 | |
Prescriptions | |||||||
Poor | 11 | 9 (5–16) | 1 | 3 (0–16) | 1 | 4 (0–20) | <0.001 |
Moderate | 16 | 14 (8–21) | 7 | 22 (9–40) | 0 | 0 | |
Good | 31 | 27 (19–35) | 1 | 3 (0–16) | 1 | 4 (0–20) | |
Excellent | 14 | 12 (7–19) | 12 | 38 (21–56) | 17 | 65 (44–83) | |
No prescriptions | 45 | 38 (30–48) | 11 | 34 (19–53) | 7 | 27 (12–48) | |
General informative value | |||||||
Poor | 22 | 19 (12–27) | 2 | 6 (1–21) | 8 | 31 (14–52) | 0.002 |
Moderate | 78 | 67 (57–75) | 16 | 50 (32–68) | 14 | 54 (33–73) | |
Good | 17 | 15 (9–22) | 44 (26–62) | 4 | 15 (4–35) |